InvestorsHub Logo
Post# of 253321
Next 10
Followers 69
Posts 6152
Boards Moderated 0
Alias Born 11/26/2008

Re: DewDiligence post# 151964

Thursday, 11/08/2012 8:58:31 PM

Thursday, November 08, 2012 8:58:31 PM

Post# of 253321

ARQL discloses departure of CSO

Never like to hear this, though the filing says he's leaving to form his own company. I'm less concerned about this I think than if he were just leaving to join another existing company. Could it be the CSO took some heat for the design of the lead tivantinib trial that bombed and decided to bolt to do his own thing?
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.